Smoking Cessation Tools in the Urological Context: Considering the Genitourinary Impacts of Smoking Cessation Tools
Abstract
:Author Contributions
Funding
Conflicts of Interest
References
- Tehrani, H.; Rajabi, A.; Ghelichi-Ghojogh, M.; Nejatian, M.; Jafari, A. The prevalence of electronic cigarettes vaping globally: A systematic review and meta-analysis. Arch. Public Health 2022, 80, 240. [Google Scholar] [CrossRef] [PubMed]
- Hajek, P.; Phillips-Waller, A.; Przulj, D.; Pesola, F.; Smith, K.M.; Bisal, N.; Li, J.; Parrott, S.; Sasieni, P.; Dawkins, L.; et al. A randomized trial of E-cigarettes versus nicotine-replacement therapy. N. Engl. J. Med. 2019, 380, 629–637. [Google Scholar] [CrossRef] [PubMed]
- Bandara, N.A.; Herath, J.; Mehrnoush, V. Addressing e-cigarette health claims made on social media amidst the COVID-19 pandemic. World J. Pediatr. 2021, 17, 3–5. [Google Scholar] [CrossRef] [PubMed]
- Banks, E.; Yazidjoglou, A.; Brown, S.; Nguyen, M.; Martin, M.; Beckwith, K.; Daluwatta, A.; Campbell, S.; Joshy, G. Electronic cigarettes and health outcomes: Umbrella and systematic review of the global evidence. Med. J. Aust. 2023, 218, 267–275. [Google Scholar] [CrossRef] [PubMed]
- Bandara, N.A.; Zhou, X.R.; Alhamam, A.; Black, P.C.; St-Laurent, M.-P. The genitourinary impacts of electronic cigarette use: A systematic review of the literature. World J. Urol. 2023, 41, 2637–2646. [Google Scholar] [CrossRef] [PubMed]
- Chen, C.-H.; Shun, C.-T.; Huang, K.-H.; Huang, C.-Y.; Tsai, Y.-C.; Yu, H.-J.; Pu, Y.-S. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU Int. 2007, 100, 281–286; discussion 286. [Google Scholar] [CrossRef] [PubMed]
- Reid, R.D.; Pritchard, G.; Walker, K.; Aitken, D.; Mullen, K.-A.; Pipe, A.L. Managing smoking cessation. CMAJ 2016, 188, E484–E492. [Google Scholar] [CrossRef] [PubMed]
- Ebbert, J.O.; Hatsukami, D.K.; Croghan, I.T.; Schroeder, D.R.; Allen, S.S.; Hays, J.T.; Hurt, R.D. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: A randomized trial: A randomized trial. JAMA 2014, 311, 155–163. [Google Scholar] [CrossRef] [PubMed]
- Formanek, P.; Salisbury-Afshar, E.; Afshar, M. Helping patients with ESRD and earlier stages of CKD to quit smoking. Am. J. Kidney Dis. 2018, 72, 255–266. [Google Scholar] [CrossRef] [PubMed]
- The Royal Australian College of General Practitioners. Supporting Smoking Cessation: A Guide for Health Professionals Org.au. 2021. Available online: https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/supporting-smoking-cessation (accessed on 25 October 2023).
- Stepanov, I.; Carmella, S.G.; Briggs, A.; Hertsgaard, L.; Lindgren, B.; Hatsukami, D.; Hecht, S.S. Presence of the carcinogen N’-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer Res. 2009, 69, 8236–8240. [Google Scholar] [CrossRef] [PubMed]
- Stepanov, I.; Sebero, E.; Wang, R.; Gao, Y.-T.; Hecht, S.S.; Yuan, J.-M. Tobacco-specific N-nitrosamine exposures and cancer risk in the Shanghai Cohort Study: Remarkable coherence with rat tumor sites: NNN in lung cancer. Int. J. Cancer 2014, 134, 2278–2283. [Google Scholar] [CrossRef] [PubMed]
- Izci, F.; Iris Koc, M.; Bilici, R.; Yalcin, M.; Bestepe, E.E. Urinary incontinence during sleep associated with extended release form of bupropion HCI. Case Rep. Psychiatry 2015, 2015, 906294. [Google Scholar] [CrossRef] [PubMed]
- Schwitalla, T.A.; Patel, R.A.; Catalano, G.; Nirmalani-Gandhy, A. Bupropion hydrochloride sustained release and diurnal enuresis: A previously unreported adverse effect. Clin. Neuropharmacol. 2019, 42, 211–213. [Google Scholar] [CrossRef] [PubMed]
- Kwong, W.; White, C.A. Varenicline induced acute interstitial nephritis in the setting of idiopathic membranous glomerulonephritis. BMC Nephrol. 2013, 14, 248. [Google Scholar] [CrossRef] [PubMed]
- Bird, M.L.; Vesta, K.S. Varenicline-associated acute renal failure. Ann. Pharmacother. 2008, 42, 1908–1911. [Google Scholar] [CrossRef] [PubMed]
- Herriges, M.J.; Pinkhasov, R.; Shapiro, O.; Jacob, J.M.; Basnet, A.; Bratslavsky, G.; Goldberg, H. E-cigarette use and the risk of bladder and lung cancer. J. Clin. Oncol. 2022, 40 (Suppl. S6), 443. [Google Scholar] [CrossRef]
- Holmboe, S.A.; Priskorn, L.; Jensen, T.K.; Skakkebaek, N.E.; Andersson, A.-M.; Jørgensen, N. Use of e-cigarettes associated with lower sperm counts in a cross-sectional study of young men from the general population. Hum. Reprod. 2020, 35, 1693–1701. [Google Scholar] [CrossRef]
- O’Neill, H. Effect of Electronic-Cigarette Flavourings on (I) Human Sperm Motility, Chromatin Integrity In Vitro and (II) Mice Testicular Function In Vivo Srf-reproduction.org. 2017. Available online: http://srf-reproduction.org/wp-content/uploads/2017/01/Fertility-2017-Final-Programme-and-Abstracts.pdf (accessed on 5 October 2023).
- Volesky, K.D.; Maki, A.; Scherf, C.; Watson, L.M.; Cassol, E.; Villeneuve, P.J. Characteristics of e-cigarette users and their perceptions of the benefits, harms and risks of e-cigarette use: Survey results from a convenience sample in Ottawa, Canada. Health Promot. Chronic Dis. Prev. Can. 2016, 36, 130–138. [Google Scholar] [CrossRef]
- Dawkins, L.; Cox, S.; Goniewicz, M.; McRobbie, H.; Kimber, C.; Doig, M.; Kośmider, L. ‘Real-world’ compensatory behaviour with low nicotine concentration e-liquid: Subjective effects and nicotine, acrolein and formaldehyde exposure: Real-world compensatory e-cigarette behaviour. Addiction 2018, 113, 1874–1882. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bandara, N.A.; Zhou, X.R.; Alhamam, A.; Black, P.C.; St-Laurent, M.-P. Smoking Cessation Tools in the Urological Context: Considering the Genitourinary Impacts of Smoking Cessation Tools. Soc. Int. Urol. J. 2024, 5, 97-100. https://doi.org/10.3390/siuj5020016
Bandara NA, Zhou XR, Alhamam A, Black PC, St-Laurent M-P. Smoking Cessation Tools in the Urological Context: Considering the Genitourinary Impacts of Smoking Cessation Tools. Société Internationale d’Urologie Journal. 2024; 5(2):97-100. https://doi.org/10.3390/siuj5020016
Chicago/Turabian StyleBandara, Nilanga Aki, Xuan Randy Zhou, Abdullah Alhamam, Peter C. Black, and Marie-Pier St-Laurent. 2024. "Smoking Cessation Tools in the Urological Context: Considering the Genitourinary Impacts of Smoking Cessation Tools" Société Internationale d’Urologie Journal 5, no. 2: 97-100. https://doi.org/10.3390/siuj5020016